Cite
MLA Citation
Isabelle Andrieux-Meyer et al.. “Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.” Lancet gastroenterology and hepatology, vol. 6, 2021, pp. 448–458. http://access.bl.uk/ark:/81055/vdc_100130758837.0x000003